SHC RSI Chart
Last 7 days
-22.2%
Last 30 days
-32.0%
Last 90 days
-32.0%
Trailing 12 Months
-11.7%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 987.5M | 976.2M | 990.6M | 1.0B |
2022 | 956.1M | 970.8M | 993.3M | 1.0B |
2021 | 842.1M | 880.9M | 907.1M | 931.5M |
2020 | 788.3M | 798.2M | 808.2M | 818.2M |
2019 | 0 | 0 | 0 | 778.3M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Mar 04, 2024 | rutz michael p | acquired | - | - | 34,270 | president of sterigenics |
Mar 04, 2024 | gtcr investment xi llc | sold | -158,283,000 | 14.3075 | -11,062,900 | - |
Mar 04, 2024 | petras michael b. jr. | sold | -14,362,900 | 14.3075 | -1,003,870 | chairman & ceo |
Mar 04, 2024 | klee ann r. | sold | -82,268 | 14.3075 | -5,750 | - |
Mar 04, 2024 | lyons jonathan m. | acquired | - | - | 41,124 | sr. vice president, cfo |
Mar 04, 2024 | warburg pincus & co. | sold | -237,424,000 | 14.3075 | -16,594,400 | - |
Mar 04, 2024 | petras michael b. jr. | acquired | - | - | 274,160 | chairman & ceo |
Mar 04, 2024 | rutz michael p | sold | -1,189,080 | 14.3075 | -83,109 | president of sterigenics |
Mar 04, 2024 | dimitrief alexander | acquired | - | - | 51,405 | svp, general counsel and sec. |
Mar 02, 2024 | petras michael b. jr. | sold (taxes) | -721,652 | 14.56 | -49,564 | chairman & ceo |
Which funds bought or sold SHC recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Mar 22, 2024 | PNC FINANCIAL SERVICES GROUP, INC. | reduced | -3.64 | 5,937 | 76,718 | -% |
Mar 11, 2024 | VANGUARD GROUP INC | added | 0.56 | 18,679,100 | 161,185,000 | -% |
Mar 01, 2024 | GOLDMAN SACHS GROUP INC | added | 92.23 | 2,975,900 | 5,536,270 | -% |
Mar 01, 2024 | Pineridge Advisors LLC | new | - | 22,646 | 22,646 | 0.01% |
Feb 28, 2024 | AMERICAN INTERNATIONAL GROUP, INC. | reduced | -4.12 | 164,591 | 2,261,510 | 0.01% |
Feb 26, 2024 | TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY | unchanged | - | 64,000 | 571,000 | -% |
Feb 22, 2024 | SIERRA SUMMIT ADVISORS LLC | new | - | 193,691 | 193,691 | 0.06% |
Feb 21, 2024 | FINDELL CAPITAL MANAGEMENT LLC | new | - | 8,425,000 | 8,425,000 | 5.30% |
Feb 16, 2024 | PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | added | 2.81 | 94,731 | 696,731 | -% |
Feb 16, 2024 | PRICE T ROWE ASSOCIATES INC /MD/ | added | 5.63 | 126,000 | 797,000 | -% |
Unveiling Sotera Health Co's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index
Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>
Returns of $10,000 invested in:
Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224
Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.
Peers (Alternatives to Sotera Health Co)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
DHR | 184.1B | 23.9B | 38.82 | 7.71 | ||||
IDXX | 44.8B | 3.7B | 53.05 | 12.25 | ||||
A | 43.2B | 6.7B | 34.96 | 6.42 | ||||
DGX | 14.5B | 9.3B | 16.99 | 1.57 | ||||
CRL | 13.8B | 4.1B | 29.14 | 3.35 | ||||
MEDP | 12.4B | 1.9B | 43.86 | 6.58 | ||||
EXAS | 12.1B | 2.5B | -59.47 | 4.86 | ||||
NTRA | 10.9B | 1.1B | -25.12 | 10.09 | ||||
MID-CAP | ||||||||
NEOG | 3.3B | 918.7M | 284.21 | 3.64 | ||||
GH | 2.2B | 563.9M | -4.56 | 3.88 | ||||
SMALL-CAP | ||||||||
CDNA | 544.7M | 280.3M | -2.86 | 1.94 | ||||
ACRS | 89.4M | 31.2M | -1.01 | 2.86 | ||||
AWH | 35.5M | 9.2M | -1.95 | 3.86 | ||||
APDN | 7.3M | 9.0M | -1.01 | 0.81 | ||||
BIOC | 183.8K | 25.9M | -0.01 | 0.01 |
Sotera Health Co News
Income Statement (Quarterly) | ||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 |
Revenue | 17.9% | 310 | 263 | 255 | 221 | 252 | 249 | 267 | 237 | 241 | 226 | 252 | 212 | 217 | 200 | 213 | 188 | - |
Cost Of Revenue | 11.1% | 130 | 117 | 116 | 109 | 110 | 113 | 116 | 108 | 107 | 101 | 108 | 97.00 | 96.00 | 93.00 | 94.00 | 92.00 | - |
Gross Profit | 23.4% | 180 | 146 | 140 | 112 | 142 | 136 | 150 | 129 | 134 | 126 | 144 | 115 | 121 | 108 | 119 | 97.00 | - |
Operating Expenses | 8.8% | 76.00 | 70.00 | 76.00 | 78.00 | 82.00 | 73.00 | 79.00 | 75.00 | 68.00 | 60.00 | 65.00 | 69.00 | 68.00 | 60.00 | 57.00 | 52.00 | - |
S&GA Expenses | 11.5% | 60.00 | 54.00 | 60.00 | 62.00 | 66.00 | 57.00 | 63.00 | 60.00 | 52.00 | 44.00 | 50.00 | 52.00 | 53.00 | 46.00 | 43.00 | 37.00 | - |
EBITDA Margin | 422.9% | 0.34* | -0.11* | -0.12* | -0.12* | -0.10* | 0.33* | 0.33* | 0.34* | 0.32* | 0.27* | 0.27* | 0.26* | - | - | - | - | - |
Interest Expenses | -68.0% | 23.00 | 72.00 | 43.00 | 35.00 | 11.00 | 23.00 | 26.00 | 16.00 | 5.00 | 17.00 | 17.00 | 20.00 | 47.00 | 51.00 | 49.00 | 64.00 | - |
Income Taxes | 91.0% | 27.00 | 14.00 | 11.00 | 3.00 | -58.78 | 17.00 | 18.00 | 15.00 | 23.00 | 14.00 | 19.00 | 3.00 | 8.00 | -1.21 | 4.00 | -12.23 | - |
Earnings Before Taxes | 13872.3% | 66.00 | 0.00 | 34.00 | 5.00 | -378 | 42.00 | 48.00 | 45.00 | 59.00 | 41.00 | 62.00 | 14.00 | -35.08 | -0.58 | 11.00 | -14.22 | - |
EBT Margin | 129.6% | 0.10* | -0.34* | -0.30* | -0.29* | -0.24* | 0.20* | 0.20* | 0.22* | 0.19* | 0.09* | 0.05* | -0.01* | - | - | - | - | - |
Net Income | 383.2% | 39.00 | -13.66 | 24.00 | 3.00 | -319 | 25.00 | 30.00 | 31.00 | 36.00 | 27.00 | 43.00 | 11.00 | -43.68 | 0.00 | 7.00 | -1.96 | - |
Net Income Margin | 115.8% | 0.05* | -0.31* | -0.27* | -0.26* | -0.23* | 0.12* | 0.13* | 0.14* | 0.13* | 0.04* | 0.01* | -0.03* | - | - | - | - | - |
Free Cashflow | 575.1% | 48.00 | -10.17 | -389 | -11.13 | 30.00 | 29.00 | 22.00 | 14.00 | 25.00 | 65.00 | 54.00 | 35.00 | - | - | - | - | - |
Balance Sheet | ||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 |
Assets | 3.1% | 3,130 | 3,037 | 3,075 | 3,414 | 3,118 | 2,811 | 2,840 | 2,836 | 2,790 | 2,743 | 2,851 | 2,777 | 2,761 |
Current Assets | 7.2% | 557 | 520 | 547 | 924 | 645 | 421 | 399 | 372 | 346 | 337 | 401 | 328 | 315 |
Cash Equivalents | 21.0% | 296 | 245 | 263 | 648 | 395 | 165 | 141 | 121 | 107 | 115 | 156 | 108 | 102 |
Inventory | 27.4% | 48.00 | 38.00 | 42.00 | 47.00 | 37.00 | 37.00 | 40.00 | 46.00 | 54.00 | 37.00 | 36.00 | 33.00 | 34.00 |
Net PPE | -100.0% | - | 884 | - | - | 775 | 704 | 700 | 669 | 651 | 624 | 624 | 612 | 610 |
Goodwill | 0.9% | 1,111 | 1,101 | 1,110 | 1,103 | 1,102 | 1,092 | 1,116 | 1,126 | 1,120 | 1,103 | 1,114 | 1,107 | 1,116 |
Liabilities | 1.0% | 2,687 | 2,659 | 2,657 | 3,053 | 2,767 | 2,204 | 2,204 | 2,194 | 2,203 | 2,217 | 2,328 | 2,311 | 2,307 |
Current Liabilities | 15.0% | 231 | 201 | 200 | 600 | 792 | 140 | 142 | 144 | 161 | 134 | 149 | 138 | 141 |
Long Term Debt | 0.0% | 2,224 | 2,223 | 2,222 | 2,222 | 1,747 | 1,747 | 1,746 | 1,745 | 1,744 | 1,743 | 1,838 | 1,838 | 1,825 |
LT Debt, Current | -8.4% | 5.00 | 5.00 | 5.00 | 4.00 | 197 | - | - | - | - | - | - | - | - |
LT Debt, Non Current | 0.0% | 2,224 | 2,223 | 2,222 | 2,222 | 1,747 | - | - | 1,745 | 1,744 | - | - | 1,838 | 1,825 |
Shareholder's Equity | 17.6% | 444 | 377 | 418 | 361 | 350 | 607 | 636 | 642 | 586 | 526 | 523 | 466 | 455 |
Retained Earnings | 5.6% | -654 | -693 | -679 | -702 | -705 | -386 | -411 | -441 | -472 | -508 | -535 | -578 | -589 |
Additional Paid-In Capital | 0.4% | 1,215 | 1,210 | 1,203 | 1,195 | 1,190 | 1,187 | 1,182 | 1,177 | 1,173 | 1,171 | 1,168 | 1,170 | 1,166 |
Shares Outstanding | 0.0% | 281 | 281 | 281 | 281 | 280 | 280 | 280 | 280 | 279 | 279 | 279 | 279 | - |
Minority Interest | - | - | - | - | - | - | - | - | - | - | - | - | 2.00 | 2.00 |
Float | - | - | - | 1,871 | - | - | - | 1,948 | - | - | - | 2,403 | - | - |
Cashflow (Quarterly) | ||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 |
Cashflow From Operations | 170.3% | 113,123 | 41,849 | -336,575 | 33,871 | 101,926 | 67,779 | 58,289 | 49,967 | 66,351 | 80,938 | 78,097 | 56,159 | 21,845 | 46,053 | 46,997 | 5,690 | - |
Share Based Compensation | -2.1% | 8,204 | 8,378 | 8,373 | 7,288 | 6,256 | 4,616 | 5,801 | 4,538 | 3,381 | 3,547 | 3,493 | 3,449 | 6,968 | 901 | 1,393 | 1,725 | - |
Cashflow From Investing | -24.7% | -64,826 | -51,978 | -53,134 | -44,968 | -71,738 | -38,966 | -35,709 | -35,483 | -72,263 | -16,596 | -24,455 | -46,519 | -18,774 | -116,482 | -10,449 | -12,989 | - |
Cashflow From Financing | -9.8% | -3,793 | -3,454 | -710 | 273,916 | 199,244 | -400 | -634 | -449 | -1,782 | -103,414 | -8,307 | -3,783 | -10,529 | 90,479 | -55,825 | 49,307 | - |
Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($) shares in Thousands, $ in Thousands | 12 Months Ended | ||
---|---|---|---|
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Revenues: | |||
Total net revenues | $ 1,049,288 | $ 1,003,687 | $ 931,478 |
Cost of revenues: | |||
Total cost of revenues | 472,130 | 446,683 | 412,806 |
Gross profit | 577,158 | 557,004 | 518,672 |
Operating expenses: | |||
Selling, general and administrative expenses | 236,667 | 245,714 | 198,158 |
Amortization of intangible assets | 63,799 | 62,940 | 63,781 |
Total operating expenses | 300,466 | 308,654 | 261,939 |
Operating income | 276,692 | 248,350 | 256,733 |
Interest expense, net | 142,878 | 80,144 | 74,192 |
Impairment of investment in unconsolidated affiliate | 0 | 9,613 | 0 |
Loss on extinguishment of debt | 0 | 0 | 20,681 |
Foreign exchange loss | 159 | 145 | 1,345 |
Other income, net | (7,372) | (6,441) | (15,201) |
Income (loss) before income taxes | 106,027 | (243,111) | 175,716 |
Provision (benefit) for income taxes | 54,651 | (9,541) | 58,595 |
Net income (loss) | 51,376 | (233,570) | 117,121 |
Less: Net income attributable to noncontrolling interests | 0 | 0 | 239 |
Net income (loss) attributable to Sotera Health Company | 51,376 | (233,570) | 116,882 |
Other comprehensive income (loss) net of tax: | |||
Pension and post-retirement benefits (net of taxes of $(3,420), $7,022 and $8,924, respectively) | (10,506) | 20,790 | 26,562 |
Interest rate derivatives (net of taxes of $(5,467), $7,387 and $142, respectively) | (15,697) | 20,939 | 404 |
Foreign currency translation | 40,174 | (64,816) | (16,395) |
Comprehensive income (loss) | 65,347 | (256,657) | 127,692 |
Less: comprehensive income attributable to noncontrolling interests | 0 | 0 | 534 |
Comprehensive income (loss) attributable to Sotera Health Company | $ 65,347 | $ (256,657) | $ 127,158 |
Earnings (Loss) per share: | |||
Basic (in dollars per share) | $ 0.18 | $ (0.83) | $ 0.41 |
Diluted (in dollars per share) | $ 0.18 | $ (0.83) | $ 0.41 |
Weighted average number of shares outstanding: | |||
Basic (in shares) | 281,008 | 280,096 | 279,228 |
Diluted (in shares) | 283,222 | 280,096 | 279,382 |
Georgia EO litigation settlement | |||
Operating expenses: | |||
Litigation settlement | $ 35,000 | $ 0 | $ 0 |
Illinois EO litigation settlement | |||
Operating expenses: | |||
Litigation settlement | 0 | 408,000 | 0 |
Service | |||
Revenues: | |||
Total net revenues | 905,598 | 864,828 | 805,501 |
Cost of revenues: | |||
Total cost of revenues | 418,611 | 390,860 | 357,205 |
Product | |||
Revenues: | |||
Total net revenues | 143,690 | 138,859 | 125,977 |
Cost of revenues: | |||
Total cost of revenues | $ 53,519 | $ 55,823 | $ 55,601 |
Consolidated Balance Sheets - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 296,407 | $ 395,214 |
Restricted cash short-term | 5,247 | 1,080 |
Accounts receivable, net of allowance for uncollectible accounts of $4,689 and $1,871 as of December 31, 2023 and 2022, respectively | 147,696 | 118,482 |
Inventories, net | 48,316 | 37,145 |
Prepaid expenses and other current assets | 53,846 | 80,995 |
Income taxes receivable | 5,732 | 12,094 |
Total current assets | 557,244 | 645,010 |
Property, plant, and equipment, net | 946,914 | 774,527 |
Operating lease assets | 24,037 | 26,481 |
Deferred income taxes | 4,993 | 4,101 |
Post-retirement assets | 28,482 | 35,570 |
Other assets | 41,242 | 38,983 |
Other intangible assets, net | 416,318 | 491,265 |
Goodwill | 1,111,190 | 1,101,768 |
Total assets | 3,130,420 | 3,117,705 |
Current liabilities: | ||
Accounts payable | 71,039 | 74,139 |
Accrued liabilities | 122,471 | 490,130 |
Deferred revenue | 13,492 | 12,140 |
Current portion of long-term debt | 4,797 | 197,119 |
Current portion of finance lease obligations | 8,771 | 1,722 |
Current portion of operating lease obligations | 5,934 | 7,554 |
Current portion of asset retirement obligations | 0 | 2,896 |
Income taxes payable | 4,150 | 5,867 |
Total current liabilities | 230,654 | 791,567 |
Long-term debt | 2,223,674 | 1,747,115 |
Finance lease obligations, less current portion | 63,793 | 56,955 |
Operating lease obligations, less current portion | 20,087 | 21,577 |
Noncurrent asset retirement obligations | 47,944 | 42,586 |
Deferred lease income | 18,762 | 18,902 |
Post-retirement obligations | 8,439 | 7,910 |
Noncurrent liabilities | 8,879 | 12,831 |
Deferred income taxes | 64,454 | 68,024 |
Total liabilities | 2,686,686 | 2,767,467 |
See Commitments and contingencies note | ||
Equity: | ||
Common stock, with $0.01 par value, 1,200,000 shares authorized; 286,037 shares issued at December 31, 2023 and 2022 | 2,860 | 2,860 |
Preferred stock, with $0.01 par value, 120,000 shares authorized; no shares issued at December 31, 2023 and 2022 | 0 | 0 |
Treasury stock, at cost (3,207 and 3,616 shares at December 31, 2023 and 2022, respectively) | (27,182) | (29,775) |
Additional paid-in capital | 1,215,178 | 1,189,622 |
Retained deficit | (654,440) | (705,816) |
Accumulated other comprehensive loss | (92,682) | (106,653) |
Total equity | 443,734 | 350,238 |
Total liabilities and equity | $ 3,130,420 | $ 3,117,705 |